Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry
about
ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia.Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacyChloroquine is a potent inhibitor of SARS coronavirus infection and spread.The SARS coronavirus S glycoprotein receptor binding domain: fine mapping and functional characterizationMechanisms of coronavirus cell entry mediated by the viral spike proteinHost cell entry of respiratory syncytial virus involves macropinocytosis followed by proteolytic activation of the F proteinEzrin interacts with the SARS coronavirus Spike protein and restrains infection at the entry stageFusion of Enveloped Viruses in Endosomes.Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infectionA neutralizing monoclonal antibody targeting the acid-sensitive region in chikungunya virus E2 protects from diseaseProteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research.SARS molecular epidemiology: a Chinese fairy tale of controlling an emerging zoonotic disease in the genomics era.DESC1 and MSPL activate influenza A viruses and emerging coronaviruses for host cell entry.Exposure to ozone modulates human airway protease/antiprotease balance contributing to increased influenza A infectionEfficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.Two-step conformational changes in a coronavirus envelope glycoprotein mediated by receptor binding and proteolysisProtease-mediated enhancement of severe acute respiratory syndrome coronavirus infection.Identification of a new region of SARS-CoV S protein critical for viral entryCleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro.Structure of a proteolytically resistant core from the severe acute respiratory syndrome coronavirus S2 fusion proteinA single tyrosine in the severe acute respiratory syndrome coronavirus membrane protein cytoplasmic tail is important for efficient interaction with spike proteinTMPRSS2 and MSPL Facilitate Trypsin-Independent Porcine Epidemic Diarrhea Virus Replication in Vero Cells.Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses.Structure, Function, and Evolution of Coronavirus Spike Proteins.Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry.Apical entry and release of severe acute respiratory syndrome-associated coronavirus in polarized Calu-3 lung epithelial cellsInhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry.Elastase-mediated activation of the severe acute respiratory syndrome coronavirus spike protein at discrete sites within the S2 domain.Type I feline coronavirus spike glycoprotein fails to recognize aminopeptidase N as a functional receptor on feline cell lines.Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans.The spike protein of SARS-CoV--a target for vaccine and therapeutic development.Palmitoylation of SARS-CoV S protein is necessary for partitioning into detergent-resistant membranes and cell-cell fusion but not interaction with M protein.A single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms.Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus.Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus.Monoclonal antibodies targeting the HR2 domain and the region immediately upstream of the HR2 of the S protein neutralize in vitro infection of severe acute respiratory syndrome coronavirus.Palmitoylations on murine coronavirus spike proteins are essential for virion assembly and infectivity.Potent and persistent antibody responses against the receptor-binding domain of SARS-CoV spike protein in recovered patients.Antiviral drugs specific for coronaviruses in preclinical developmentProtease inhibitors targeting coronavirus and filovirus entry
P2860
Q24538811-B100E417-B716-4953-A541-0681C3364967Q24701766-99B859F8-4D9E-4BA2-82F2-93D650400EF4Q24815979-C46E59F8-2CA1-482B-A11A-54639451495CQ24817089-56F04835-57D7-4956-98CA-AB7420F66A9AQ27027678-0469A88A-87CE-4777-8CE5-CFC0030CCFA4Q27335061-6020C96F-834E-4202-B748-F68931903CFCQ27335547-3205A603-33ED-476D-BB85-BEDEB40223D4Q28073406-CAF7A233-1DC1-4E33-A8DB-6F6CD3E055ABQ28383088-5F93BE69-2372-4930-B0F4-4602824FFA46Q28533408-E9D97DD7-6B21-44B3-A1A3-4CC36A89EEA1Q30354466-8E48A1A4-F3B6-477A-9C72-AEB0FBB68768Q30360085-57AA9DEB-8487-48FC-81A8-D8170E91F564Q30365699-0546B847-A80B-4F7D-9379-7C4F5F00CF8CQ30415297-39CBF103-9CE3-4F1A-AECD-B3FC6BABC045Q30432156-7DE08C60-68CB-494C-B115-DBBB2D3E7BE3Q30436297-315E3EB3-1146-4B63-8DF0-1462E00E63C6Q30447031-1F15D8C7-C25A-40FA-883D-793ABBEA4829Q33512190-1F944202-EB67-4188-BDE3-278585E161D0Q33516234-E2E191D3-BE9E-401B-AC25-E8D22F04D1C9Q33581892-B94A445C-219B-490D-AD2C-8E511BD96090Q33614610-8AECE68E-E9DC-487E-840A-5215ADC3386AQ33753975-4F612CE4-26D5-465E-8C5B-8D41032A1635Q33756740-347A1447-8F45-41AE-AE66-9E8FCC4CD34DQ33760875-1497CC48-9C42-40BD-9201-319AED1DC4EEQ33841118-B1D134A3-C5F5-479A-9C86-549704546585Q33908658-F3E158D0-8AC2-4CBB-8189-CC7485351283Q33920306-70506D6E-941C-489E-82DB-F728A7303F5EQ34003783-24BBD48D-01AB-42E7-9118-58016CB77B4DQ34004016-77603BB8-77EB-45B8-AFA1-C698EF941B1EQ34009523-5F2C1549-4D90-40A4-BED1-4E229665F226Q34015988-060377BC-197D-43B5-94D3-77613ED4DD96Q34037293-8DFFC8A6-F2E7-49BD-9AD0-F286D004F5DAQ34055469-4EC37A8B-D37D-43E3-A73E-580E378AFBDCQ34120263-9574C4B4-254C-4A48-BACD-6456229AE38FQ34193942-C61C0403-1591-49A0-A121-9A5179A3A776Q34301708-4BC30696-8BEB-4D7D-9C57-E291E76D7498Q34302034-942D287D-01C1-4FFE-AC3F-FF09F80765EAQ34332142-55194D71-AABD-49E7-A7CD-938A21DEC180Q34332580-FB7DCFC0-080A-4033-9D38-7A6FFFEAEB51Q34461982-95C3E52C-A0C0-49C9-9AEB-4CF8A24C1729
P2860
Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 March 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Characterization of severe acu ...... coprotein-mediated viral entry
@en
Characterization of severe acute respiratory syndrome-associated coronavirus
@nl
type
label
Characterization of severe acu ...... coprotein-mediated viral entry
@en
Characterization of severe acute respiratory syndrome-associated coronavirus
@nl
prefLabel
Characterization of severe acu ...... coprotein-mediated viral entry
@en
Characterization of severe acute respiratory syndrome-associated coronavirus
@nl
P2093
P2860
P50
P356
P1476
Characterization of severe acu ...... coprotein-mediated viral entry
@en
P2093
Andrew J Piefer
Jacqueline D Reeves
Sean M Amberg
P2860
P304
P356
10.1073/PNAS.0306446101
P407
P577
2004-03-09T00:00:00Z